©2024 Stanford Medicine
Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Not Recruiting
Trial ID: NCT05074667
Purpose
The purpose of this pilot feasibility study is to provide continued CGM access to youth with
type 2 diabetes and collect descriptive data about feasibility of use of CGM in youth with
type 2 diabetes ages 4 years and older. From this study the investigators hope to learn if
CGM use in youth with type 2 diabetes can be tolerated and sustained with good adherence and
to describe blood glucose patterns in youth with type 2 diabetes. The primary aim will be to
evaluate the feasibility of CGM start and continuation in youth with T2D and describe glucose
metrics and patient reported outcomes (PROs). The investigators will pilot and refine a
program to test the hypothesis that CGM start and continuation in youth with T2D is feasible
and then evaluate glucose metrics and PROs.
Official Title
Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
- public insurance
- between ages 4-19.99 years inclusive
- diagnosis of T2D (diabetes autoantibody negative) followed in the Pediatric
Endocrinology clinic at Stanford Children's Health
- HbA1C greater than 6.5% at enrollment
- interested in starting on a continuous glucose monitor
- have access to a mobile device that is compatible with CGM applications or willing to
use CGM receiver provided
Exclusion Criteria:
- non-T2D diagnosis
- HgA1C < 6.5%
- are not willing to wear CGM
- have private health insurance.
Intervention(s):
device: Continuous Glucose Monitor
other: Patient Reported Outcome Questionnaires
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Sejal Shah, MD
6504987351